Cargando…

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

BACKGROUND: Genetic variants within the APOE locus may modulate Alzheimer’s disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our understanding of APOE pathophysiology and provide critical guidance for AD t...

Descripción completa

Detalles Bibliográficos
Autores principales: Belloy, Michael E., Eger, Sarah J., Le Guen, Yann, Damotte, Vincent, Ahmad, Shahzad, Ikram, M. Arfan, Ramirez, Alfredo, Tsolaki, Anthoula C., Rossi, Giacomina, Jansen, Iris E., de Rojas, Itziar, Parveen, Kayenat, Sleegers, Kristel, Ingelsson, Martin, Hiltunen, Mikko, Amin, Najaf, Andreassen, Ole, Sánchez-Juan, Pascual, Kehoe, Patrick, Amouyel, Philippe, Sims, Rebecca, Frikke-Schmidt, Ruth, van der Flier, Wiesje M., Lambert, Jean-Charles, He, Zihuai, Han, Summer S., Napolioni, Valerio, Greicius, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815198/
https://www.ncbi.nlm.nih.gov/pubmed/35120553
http://dx.doi.org/10.1186/s13195-022-00962-4
_version_ 1784645233225498624
author Belloy, Michael E.
Eger, Sarah J.
Le Guen, Yann
Damotte, Vincent
Ahmad, Shahzad
Ikram, M. Arfan
Ramirez, Alfredo
Tsolaki, Anthoula C.
Rossi, Giacomina
Jansen, Iris E.
de Rojas, Itziar
Parveen, Kayenat
Sleegers, Kristel
Ingelsson, Martin
Hiltunen, Mikko
Amin, Najaf
Andreassen, Ole
Sánchez-Juan, Pascual
Kehoe, Patrick
Amouyel, Philippe
Sims, Rebecca
Frikke-Schmidt, Ruth
van der Flier, Wiesje M.
Lambert, Jean-Charles
He, Zihuai
Han, Summer S.
Napolioni, Valerio
Greicius, Michael D.
author_facet Belloy, Michael E.
Eger, Sarah J.
Le Guen, Yann
Damotte, Vincent
Ahmad, Shahzad
Ikram, M. Arfan
Ramirez, Alfredo
Tsolaki, Anthoula C.
Rossi, Giacomina
Jansen, Iris E.
de Rojas, Itziar
Parveen, Kayenat
Sleegers, Kristel
Ingelsson, Martin
Hiltunen, Mikko
Amin, Najaf
Andreassen, Ole
Sánchez-Juan, Pascual
Kehoe, Patrick
Amouyel, Philippe
Sims, Rebecca
Frikke-Schmidt, Ruth
van der Flier, Wiesje M.
Lambert, Jean-Charles
He, Zihuai
Han, Summer S.
Napolioni, Valerio
Greicius, Michael D.
author_sort Belloy, Michael E.
collection PubMed
description BACKGROUND: Genetic variants within the APOE locus may modulate Alzheimer’s disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our understanding of APOE pathophysiology and provide critical guidance for AD therapies aimed at APOE. The APOE locus however remains relatively poorly understood in AD, owing to multiple challenges that include its complex linkage structure and uncertainty in APOE*2/3/4 genotype quality. Here, we present a novel APOE*2/3/4 filtering approach and showcase its relevance on AD risk association analyses for the rs439401 variant, which is located 1801 base pairs downstream of APOE and has been associated with a potential regulatory effect on APOE. METHODS: We used thirty-two AD-related cohorts, with genetic data from various high-density single-nucleotide polymorphism microarrays, whole-genome sequencing, and whole-exome sequencing. Study participants were filtered to be ages 60 and older, non-Hispanic, of European ancestry, and diagnosed as cognitively normal or AD (n = 65,701). Primary analyses investigated AD risk in APOE*4/4 carriers. Additional supporting analyses were performed in APOE*3/4 and 3/3 strata. Outcomes were compared under two different APOE*2/3/4 filtering approaches. RESULTS: Using more conventional APOE*2/3/4 filtering criteria (approach 1), we showed that, when in-phase with APOE*4, rs439401 was variably associated with protective effects on AD case-control status. However, when applying a novel filter that increases the certainty of the APOE*2/3/4 genotypes by applying more stringent criteria for concordance between the provided APOE genotype and imputed APOE genotype (approach 2), we observed that all significant effects were lost. CONCLUSIONS: We showed that careful consideration of APOE genotype and appropriate sample filtering were crucial to robustly interrogate the role of the APOE locus on AD risk. Our study presents a novel APOE filtering approach and provides important guidelines for research into the APOE locus, as well as for elucidating genetic interaction effects with APOE*2/3/4. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-00962-4.
format Online
Article
Text
id pubmed-8815198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88151982022-02-07 Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping Belloy, Michael E. Eger, Sarah J. Le Guen, Yann Damotte, Vincent Ahmad, Shahzad Ikram, M. Arfan Ramirez, Alfredo Tsolaki, Anthoula C. Rossi, Giacomina Jansen, Iris E. de Rojas, Itziar Parveen, Kayenat Sleegers, Kristel Ingelsson, Martin Hiltunen, Mikko Amin, Najaf Andreassen, Ole Sánchez-Juan, Pascual Kehoe, Patrick Amouyel, Philippe Sims, Rebecca Frikke-Schmidt, Ruth van der Flier, Wiesje M. Lambert, Jean-Charles He, Zihuai Han, Summer S. Napolioni, Valerio Greicius, Michael D. Alzheimers Res Ther Research BACKGROUND: Genetic variants within the APOE locus may modulate Alzheimer’s disease (AD) risk independently or in conjunction with APOE*2/3/4 genotypes. Identifying such variants and mechanisms would importantly advance our understanding of APOE pathophysiology and provide critical guidance for AD therapies aimed at APOE. The APOE locus however remains relatively poorly understood in AD, owing to multiple challenges that include its complex linkage structure and uncertainty in APOE*2/3/4 genotype quality. Here, we present a novel APOE*2/3/4 filtering approach and showcase its relevance on AD risk association analyses for the rs439401 variant, which is located 1801 base pairs downstream of APOE and has been associated with a potential regulatory effect on APOE. METHODS: We used thirty-two AD-related cohorts, with genetic data from various high-density single-nucleotide polymorphism microarrays, whole-genome sequencing, and whole-exome sequencing. Study participants were filtered to be ages 60 and older, non-Hispanic, of European ancestry, and diagnosed as cognitively normal or AD (n = 65,701). Primary analyses investigated AD risk in APOE*4/4 carriers. Additional supporting analyses were performed in APOE*3/4 and 3/3 strata. Outcomes were compared under two different APOE*2/3/4 filtering approaches. RESULTS: Using more conventional APOE*2/3/4 filtering criteria (approach 1), we showed that, when in-phase with APOE*4, rs439401 was variably associated with protective effects on AD case-control status. However, when applying a novel filter that increases the certainty of the APOE*2/3/4 genotypes by applying more stringent criteria for concordance between the provided APOE genotype and imputed APOE genotype (approach 2), we observed that all significant effects were lost. CONCLUSIONS: We showed that careful consideration of APOE genotype and appropriate sample filtering were crucial to robustly interrogate the role of the APOE locus on AD risk. Our study presents a novel APOE filtering approach and provides important guidelines for research into the APOE locus, as well as for elucidating genetic interaction effects with APOE*2/3/4. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-00962-4. BioMed Central 2022-02-04 /pmc/articles/PMC8815198/ /pubmed/35120553 http://dx.doi.org/10.1186/s13195-022-00962-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Belloy, Michael E.
Eger, Sarah J.
Le Guen, Yann
Damotte, Vincent
Ahmad, Shahzad
Ikram, M. Arfan
Ramirez, Alfredo
Tsolaki, Anthoula C.
Rossi, Giacomina
Jansen, Iris E.
de Rojas, Itziar
Parveen, Kayenat
Sleegers, Kristel
Ingelsson, Martin
Hiltunen, Mikko
Amin, Najaf
Andreassen, Ole
Sánchez-Juan, Pascual
Kehoe, Patrick
Amouyel, Philippe
Sims, Rebecca
Frikke-Schmidt, Ruth
van der Flier, Wiesje M.
Lambert, Jean-Charles
He, Zihuai
Han, Summer S.
Napolioni, Valerio
Greicius, Michael D.
Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title_full Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title_fullStr Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title_full_unstemmed Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title_short Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
title_sort challenges at the apoe locus: a robust quality control approach for accurate apoe genotyping
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815198/
https://www.ncbi.nlm.nih.gov/pubmed/35120553
http://dx.doi.org/10.1186/s13195-022-00962-4
work_keys_str_mv AT belloymichaele challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT egersarahj challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT leguenyann challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT damottevincent challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT ahmadshahzad challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT ikrammarfan challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT ramirezalfredo challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT tsolakianthoulac challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT rossigiacomina challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT jansenirise challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT derojasitziar challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT parveenkayenat challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT sleegerskristel challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT ingelssonmartin challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT hiltunenmikko challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT aminnajaf challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT andreassenole challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT sanchezjuanpascual challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT kehoepatrick challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT amouyelphilippe challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT simsrebecca challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT frikkeschmidtruth challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT vanderflierwiesjem challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT lambertjeancharles challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT hezihuai challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT hansummers challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT napolionivalerio challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping
AT greiciusmichaeld challengesattheapoelocusarobustqualitycontrolapproachforaccurateapoegenotyping